Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021

Persistence Market Research

Acute Myeloid Leukemia Market: Global

Industry Analysis and Forecast 2015 - 2021

Persistence Market Research

Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021
Persistence Market Research Released New Market Report on Acute Myeloid Leukemia
Market: Global Industry Analysis and Forecast 2015 - 2021.
Acute Myeloid Leukemia (AML) is classed as an orphans disease. AML is a rare but a severe
disease and is a most common leukemia. It is primarily a disease of the elderly, with an average
age of diagnosis of approximately 66. AML results from the acquired changes in the DNA of a
developing marrow cell. The marrow cells get converted into the leukemic cells, multiplies into
11 billion or more. AML affects the normal cells which are partially developed and further these
cells are unable to perform their functions. These cells are known as leukemia blasts. Leukemia
blast grows and survives better than normal cells and also blocks the production of normal cells.
AML is developed in an individual due to the recurrent exposure to element benzene since
benzene damages the DNA of a normal marrow cells. As per the Toxic Substance and Disease
registry, petroleum products contributes to the majority of benzene in atmosphere half of the
exposure to benzene comes from cigarette smoke. AML cases are also seen in patients
undergoing chemotherapy (alkylating agents or topoisomerase II inhibitors) or radiation therapy.
People with genetic disorders such as Shwachman syndrome, Down syndrome, Diamond
Blackfan Syndrome are associated with a risk of AML. Also people with certain blood disorder
can develop AML.
According to the American Cancer Society of U.S.A (2015) states that around 54,270 new cases
of all kind of Leukemia were detected in 2015, out of which 20,830 cases were found to be of
AML and 10,640 deaths were due to AML and. It also states that AML is found to be more
common in men than in women.
The segmentation of Acute Myeloid Leukemia market is done on the basis of drugs, pipeline
analysis and geography. On the basis of drugs it is classified as Daunorubicin, Vidaza,
Dagogen, Busulfan, Idarubicin and Others The pipeline analysis is a complete evaluation of the
pipeline for AML treatments, with specific analysis of a number of late stage (phase III) pipeline
drugs that have the potential to enter the market during the forecast period and early stage
(Phase I and Phase II) also. The pipeline is evaluated on the origin of phase distribution,
molecule targets, molecular types and administration routes. An added in-depth examination of
pipeline drug clinical trials by phase, trial size and trial duration On the basis of the geography,
the acute myeloid leukemia market can be classified into North America, Asia Pacific, Latin
America, Europe, and Rest of the World. The market of AML is dominated by North America and
is followed by Europe and Asia Pacific. North America is reported to have the largest market
share due to the aging population and the maximum cases of AML being detected.

Persistence Market Research

Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021
Interested in report: Please follow the below the links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/7454
The AML market will grow faster in the coming years due to the rising exposure to benzene,
increasing incidences of chemotherapy and radiation therapy, Novel drug therapies, increasing
aging population and the unmet needs of the market. Whereas increasing number of stem cell
transplant, lack of standardized treatment and market being heavily dominated with the generics
act as a barrier in the AML market.
Request TOC (table of content), Figures
http://www.persistencemarketresearch.com/toc/7454

and

Tables

of

the

Report:

The major players in AML market are Johnson & Johnson Private Limited, Pfizer Inc. Abbott,
AstraZeneca, Bayer, Celgene Corporation, Ambit Biosciences Corporation, Cyclacel
Pharmaceuticals Inc. Novartis AG and Sanofi.
For more Info: http://www.persistencemarketresearch.com/contact-us.asp
The report covers exhaustive analysis on:

Acute Myeloid Leukemia Market Segments

Acute Myeloid Leukemia Market Dynamics

Historical Actual Market Size, 2012 - 2014

Acute Myeloid Leukemia Market Size & Forecast 2015 to 2025

Supply & Demand Value Chain

Acute Myeloid Leukemia Market Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Acute Myeloid Leukemia Market Drivers and Restraints

Regional analysis for Acute Myeloid Leukemia Market includes

North America

Latin America

Persistence Market Research

Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021

Europe

Asia Pacific & Japan

The Middle East and Africa

Report Highlights:

Shifting Industry dynamics

In-depth market segmentation

Historical, current and projected industry size Recent industry trends

Key Competition landscape

Strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards market performance

Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
North America
Europe
Asia
RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full All Upcoming Persistence Market's report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us:
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
Persistence Market Research

Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMRs Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.

Facilitating Rapid and Informed Business Decisions

PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number.
1-800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/

Persistence Market Research